Simultaneous and sensitive measurement of anabasine, nicotine, and nicotine metabolites in human urine by liquid chromatography - Tandem mass spectrometry

Clinical Chemistry

Volumn 50, Issue 12, 2004, Pages 2323-2330

  Xu, Xu ^a,c   Iba, Michael M ^b   Weisel, Clifford P ^a,c  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABASINE; NICOTINE; NICOTINE DERIVATIVE;

ACCURACY; ARTICLE; AUTOANALYSIS; HUMAN; LIQUID CHROMATOGRAPHY; RELIABILITY; SMOKING; TANDEM MASS SPECTROMETRY; URINALYSIS;

ANABASINE; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; NICOTINE; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION;

NICOTIANA TABACUM;

EID: 9244235029     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.038489     Document Type: Article

References (20)

1. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999;107(Suppl 2):349-55.
2. Bernert JT Jr, Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK, et al. Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 1997;43:2281-91.
3. Bentley MC, Abrar M, Kelk M, Cook J, Phillips K. Validation of an assay for the determination of cotinine and 3-hydroxycotinine in human saliva using automated solid-phase extraction and liquid chromatography with tandem mass spectrometric detection. J Chromatogr B Biomed Sci Appl 1999;723:185-94.
4. Tuomi T, Johnsson T, Reijula K. Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry. Clin Chem 1999;45:2164-72.
5. Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, et al. Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 1998;38:510-6.
6. Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, et al. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol 1998;38:502-9.
7. Benowitz NL, Jacob P 3rd, Fong I, Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994;268:296-303.
8. Boswell C, Curvall M, Elswick R Jr, Leyden D. Modeling nicotine intake in smokers and snuff users using biological fluid nicotine metabolites. Biomarkers 2000;5:341-5.
9. Davis RA, Curvall M. Determination of nicotine and its metabolites in biological fluids: in vivo studies. In: Gorrod JW, Jocob P, eds. Analytical determination of nicotine and related compounds and their metabolites. Amsterdam: Elsevier Science, 1999:583-643.
10. McManus KT, deBethizy JD, Garteiz DA, Kyerematen GA, Vesell ES. A new quantitative thermospray LC-MS method for nicotine and its metabolites in biological fluids. J Chromatogr Sci 1990;28:510-6.
11. Byrd GD, Chang KM, Greene JM, deBethizy JD. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3′-hydroxycotinine in smokers. Drug Metab Dispos 1992;20:192-7.
12. Meger M, Meger-Kossien I, Schuler-Metz A, Janket D, Scherer G. Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002;778:251-61.
13. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, et al. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin Chem 2002;48:1460-71.
14. Jacob P 3rd, Yu L, Benowitz NL. Determination of nicotine, its major metabolites, and deuterium-labeled isotopomers in human urine using LC-MS/MS [Abstract]. Drug Metab Rev 2002;34:160.
15. Pokorski TL, Chen WW, Bertholf RL. Use of urine cotinine to validate smoking self-reports in U.S. Navy recruits. Addict Behav 1994;19:451-4.
16. International Conference on Harmonization (ICH). Q2b: validation of analytical procedures: methodology. Fed Regist 1997;62:27463.
17. Xu AS, Peng LL, Havel JA, Petersen ME, Rene JA, Hulse JD. Determination of nicotine and cotinine in human plasma by liquid chromatography-tandem mass spectrometry with atmospheric-pressure chemical ionization interface. J Chromatogr B Biomed Appl 1996;682:249-57.
18. Iba MM, Fung J, Pak YW, Thomas PE, Fisher H, Sekowski A, et al. Dose-dependent up-regulation of rat pulmonary, renal, and hepatic cytochrome P-450 (CYP) 1A expression by nicotine feeding. Drug Metab Dispos 1999;27:977-82.
19. Curvall M, Kazemi-Vala E, Englund G. Conjugation pathways in nicotine metabolism. In: Adlkofer F, Thuraus K, eds. Effects of nicotine on biological systems. Basel: Birkhauser-Verlag, 1991:69-75.
20. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I. J Clin Chem Clin Biochem 1983;21:709-20.